Skip to content

Music Therapy for Depression: A Randomized Controlled Trial to Evaluate Psychobiological Effects of Music Therapy on Depression in Adult Women

Music Therapy for Depression: A Randomized Controlled Trial to Evaluate Psychobiological Effects of Music Therapy on Depression in Adult Women - MUSED

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00016616
Enrollment
74
Registered
2019-02-21
Start date
2019-07-29
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32.0 F32.1 F32.2 F32.8 F32.9 F33.0 F33.1 F33.2 F33.8 F33.9 F34.1

Interventions

Group 1: Treatment as usual + Music therapy (anamnestic interview + 10 weeks, weekly 120 minutes, group setting) Group 2: Waitlist control group (10 weeks treatment as usual). The participants are off

Sponsors

Universitätsklinikum Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Participants will be included if they (a) are female, (b) are between 18 and 65 years old, (c) meet the criteria for a current depressive disorder (without psychotic symptoms) or dysthymia according to Diagnostic and Statistical Manual of Mental Disorders (DSM-V), respectively, according to International Classification of Diseases (ICD) 10 codes: F32.0; F32.1; F32.3; F32.8; F32.9; F33.0; F33.1; F33.2; F33.8; F33.9; F34.1, (d) meet the criteria for at least a mild depression diagnosed with the observer-rating Hamilton Depression Rating Scale of Depression (HDRS) and (e) meet the criteria for at least a mild depression diagnosed with the self-rating Beck Depression Inventory (BDI-II). A remitted depression will not be eligible for participation.

Exclusion criteria

Exclusion criteria: Participants will be excluded if they (a) meet the DSM-IV criteria for severe mental disorders (schizophrenia, bipolar disorder, acute suicidal tendency, psychotic symptoms), (b) have a borderline personality disorder, (c) meet the criteria for substance abuse or acute addiction, or (d) participate or participated in another music therapy (currently or during the last three months).

Design outcomes

Primary

MeasureTime frame
The primary outcome measure for the proposed study is the decrease of depressive symptoms from pre to post intervention measured by the observer-rated Hamilton Depression Rating Scale.

Secondary

MeasureTime frame
a) self-rated depression measured with Beck Depression Inventory II (pre, post, follow-up) b) functionality of the hypothalamic-pituitary-adrenal axis indexed by diurnal cortisol pattern within days (pre, post) c) changes in circadian heart rate variability measured with 48-hours-ECG (pre, post) d) self-ratings of diverse psychological constructs in daily life to identify potential covariates via ecological momentary assessment (pre, post) Measurement of b), c) and d) proceeds parallely. e) further self-ratings of psychological constructs: stress*, emotion regulation through music, music preference, coping, quality of life, loneliness, social suport, evaluation of social systems (pre, post) *self-rated stress will additionally be measured during the intervention phase (once a week)

Countries

Germany

Contacts

Public ContactChristine Gäbel

Institut für Medizinische Psychologie

christine.gaebel@med.uni-heidelberg.de+49 6221 56-8134

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026